2023 PDA Planova S20N Evaluation on PCC and IgG Products’ Webinar

Register Now
Ask a Question Exhibitor Standard Contract Clause

Dear Colleagues,

Ensuring the viral safety of plasma-derived medicinal products is paramount, and viral clearance by purification processes is integral to achieving this. At Prothya Biosolutions B.V., the use of Planova 20N filters has reliably demonstrated a robust capacity for mitigating the risk of adventitious viruses in PCC and IgG products.

Recently, Asahi Kasei introduced its next-generation regenerated cellulose virus filter, Planova S20N. This new model promises “superior” filtration performance, “secure” robust virus removal capability, and “simplified” operation for post-use integrity testing. Invited by Asahi Kasei to evaluate the potential integration of Planova S20N filters into our manufacturing process, Prothya Biosolutions B.V. has undertaken a comparative study of these filters with the existing Planova 20N filters. Protein filtration capacity studies for both products are performed. A comparison regarding the effective filter area to be used per manufacturing batch and other process parameters is made.

Additionally, virus validation studies were conducted at ViruSure in Vienna, Austria, to verify the virus removal capability of the Planova S20N filter. The findings of these comprehensive studies and evaluations are presented in this webinar.

Please make sure to register with your company email address.

Looking forward to seeing you online!

Standard Registration

Member Price


GovernmentMember Only


Health AuthorityMember Only


Early Career ProfessionalMember Only


StudentMember Only


AcademicMember Only




See Qualifying Criteria for Member Types.


WAYS TO REGISTER: 1. Online Registration   2. [email protected]

PDA MEMBERS: Please remember to log in before registering If you come from a Governmental or Health Authority Institution or from an Academic Organization, please contact [email protected] before registering.

If you need to apply for a visa to enter the event country, PDA Europe must be informed of this fact at least 4 weeks before the start of the event.

Day 1

14:00 - 14:05 I Welcome and Introduction

14:05 – 14:35 I Planova S20N Evaluation on PCC and IgG Products’
Presenter: Ingrid Prins-de Nijs, Prothya Biosolutions B.V

14:35 – 14:40 I Poll Questions

14:40 – 15:00 I Q&A

Agenda is subject to change.

PLEASE READ  PDA is not affiliated or contracted with any outside hotel contracting company. If someone other than PDA or the PDA chosen hotel contacts you suggesting that they represent any PDA event, they do not. It is PDA's recommendation that you book your hotel directly through the official PDA chosen hotel that is listed on our web site.